NUVATION BIO INC (NUVB)
US67080N1019 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A -0.40% | N/A 2,938.92% | N/A 133.96% | N/A 91.12% | N/A 13.38% | N/A 42.32% | N/A 30.48% | |||||||
| EBITDA YoY % growth | N/A | -32.09M | -43.45M -35.40% | -93.14M -114.36% | -112.13M -20.39% | -99.6M 11.17% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -740K | -32.1M -4,237.84% | -43.55M -35.67% | -93.32M -114.28% | -112.33M -20.37% | -99.822M 11.14% | N/A -499.97% | N/A 62.94% | N/A 3.09% | N/A 17.79% | N/A 52.47% | N/A 63.93% | N/A 281.64% | N/A 205.29% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -0.44 -180.11% | -0.48 -9.09% | -0.34 29.17% | N/A -551.00% | N/A 71.20% | N/A 0.80% | N/A 59.68% | N/A 120.00% | N/A -1,120.00% | N/A -3.92% | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.14 -133.75% | -0.14 -104.00% | -0.15 1.40% | -0.17 -15.60% | -0.19 -38.18% |
| Revenue Q2Q % growth | -100.00% | -100.00% | 1.632M | ||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -49.589M -138.06% | -58.344M -188.85% | -64.26M -41.81% | -68.748M -42.92% | -73.644M -48.51% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.15 -66.67% | -0.13 | -0.02 | -13.12% |
| Q2 2024 Q2Q % growth | -0.15 -66.67% | -0.06 | -0.09 | -151.38% |
| Q1 2024 Q2Q % growth | -0.07 30.00% | -0.10 | 0.03 | 28.36% |
| Q4 2023 Q2Q % growth | -0.06 40.00% | -0.11 | 0.05 | 43.89% |
| Q3 2023 Q2Q % growth | -0.09 25.00% | -0.11 | 0.02 | 19.54% |
| Q2 2023 Q2Q % growth | -0.09 43.75% | -0.11 | 0.02 | 21.10% |
| Q1 2023 Q2Q % growth | -0.10 | -0.10 | 0.00 | 1.96% |
| Q4 2022 Q2Q % growth | -0.10 16.67% | -0.12 | 0.02 | 14.75% |
| Q3 2022 Q2Q % growth | -0.12 -9.09% | -0.14 | 0.02 | 15.97% |
| Q2 2022 Q2Q % growth | -0.16 -77.78% | -0.14 | -0.02 | -18.07% |
| Q1 2022 Q2Q % growth | -0.10 16.67% | -0.15 | 0.05 | 31.92% |
| Q4 2021 Q2Q % growth | -0.12 -152.08% | -0.12 | 0.00 | 0.58% |
| Q3 2021 Q2Q % growth | -0.11 | -0.11 | 0.00 | -1.74% |
| Q2 2021 Q2Q % growth | -0.09 | -0.10 | 0.01 | 9.96% |
| Q1 2021 Q2Q % growth | -0.12 | -0.07 | -0.05 | -68.07% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -74.05% | 0% | 0.12% |
| Revenue | N/A | N/A | 0% | 52.54% |